共 109 条
- [1] Dispenzieri A(2003)POEMS syndrome: definitions and long-term outcome BLOOD 101 2496-2506
- [2] Kyle RA(2015)POEMS syndrome: a rare disease with a challenging diagnosis Bol Asoc Med P R 107 85-88
- [3] Lacy MQ(2007)Endocrinopathy in POEMS syndrome: the Mayo Clinic experience Mayo Clin Proc 82 836-842
- [4] Rajkumar SV(2014)POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management Am J Hematol 89 214-223
- [5] Therneau TM(2012)Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy J Neurol Neurosurg Psychiatry 83 476-479
- [6] Larson DR(1980)Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature Medicine (Baltimore) 59 311-322
- [7] Greipp PR(2012)Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome Neurology. 79 575-582
- [8] Witzig TE(2011)The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome Blood. 118 4663-4665
- [9] Basu R(1983)Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases Jpn J Clin Oncol 13 543-555
- [10] Suarez GA(2015)Clinicopathologic analysis of POEMS syndrome and related diseases Clin Lymphoma Myeloma Leuk 15 e15-e21